Ariad Pharmaceuticals, Inc. (ARIA): Healthcare-focused Sarissa Capital Inches Up Its Stake to 6.87%

As a new filing with the Securities and Exchange Commission showed, Sarissa Capital Management, a fund led by Alex Denner, has picked up its position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) to 12.85 million shares, from 12.0 million disclosed previously. Following the increase, Sarissa’s activist position ammounts to 6.87% of the company’s outstanding common stock. The total value of the holding amounts to $79.93 million at the current price of the stock.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is a $1.14 billion biopharmaceuticals company engaged in research, development and commercialization of drugs for the cancer patients. The company’s stock has not performed well, dropping significantly in the last quarter of 2013, and currently trading 65% down over the past 52-weeks. Ariad Pharmaceuticals reported a net loss of $56.9 million, equal to $0.30 per share for the second quarter of the year, narrowing it from $69 million, or $0.37 per share posted for the same period of last year.

In addition, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stated that it is collaborating with the U.S. Food and Drug Administration and the European Medicines Agency to complete its randomized trial on its Iclusig drug. The company plans to reach an agreement and sign a protocol by the end of this year.

While Sarissa is the largest shareholder of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) among the funds we track, several other investors also own significant positions in the company and seem to be bullish on it. Jim Simons‘ Renaissance Technologies has almost doubled his stake during the second quarter and reported holding 4.40 million shares in its latest 13F filing. Cliff Asness‘ AQR Capital Management has boosted its stake by over 300% to 3.88 million shares during the same period.

Sarissa Capital is a healthcare-focused hedge fund with an equity portfolio of around $294 million, where Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) represents the largest position in terms of value. Aside from that, the fund owns 2.0 million shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) and 775,000 shares of Quest Diagnostics Inc (NYSE:DGX), which represent the second and third positions in terms of value respectively.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

The 10 Biggest Tax Havens in the World to Stash Your Money

The 15 Most Murderous Countries in the World

10 Largest Colleges in the World: Bigger Isn’t Always Better

Comedians in Cars Getting Coffee: The 6 Comedians Seinfeld Needs to Interview

Easy Money: The 10 Most Successful Investors in the World Today

The 10 Most Deadly Diseases in the World Today

The 5 Most Expensive Luxury Motorhomes in the World

20 Largest Stock Exchanges in the World

6 Richest Painters In The World 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!